TCL Archive NIH, FDA to tighten, review consulting rules as Congressional inquiry continues. May 21, 2004
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Scientific, Funding Challenges Test NCI Prevention Effort, Broder Says In First Speech to DCPC Board February 3, 1989
TCL Archive A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis October 19, 2012
